Our findings revealed a strong relationship between serum GDF-15 concentrations and the disease spectrum (ranging from SMM to ISS stage III MM), as well as correlations between circulating GDF-15 and indices of tumor burden (albumin, β2-microglobulin), which fall in line with earlier reports ([26]; J. [11]). This evidence concerns the gene ALB and Miyoshi myopathy.